chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Discharge Provider:  Primary Care Provider: Admission Date: 7/17/2022 Discharge Date: 7/19/22  PRESENTING PROBLEM: Essential hypertension  Generalized weakness  Elevated troponin  Dystonic drug reaction  Anxiety disorder, unspecified type Non-intractable vomiting with nausea, unspecified vomiting type COVID-19   HOSPITAL COURSE: Pt is a 78-year-old female with PMH significant for RA (prednisone, methotrexate, Plaquenil) and hypertension who presented to the hospital 7/17 due to worsening nausea and vomiting over the past 6 months. Patient has been having intermittent n/v over the past year but it has progressed to daily over the past six months. Symptoms are generally exertional and come on with ambulation or lifting heavy objects. Patient does not note an association with dizziness and her nausea. She also does not note any correlation with PO intake or constipation and nausea.  Previously PCP I requested a CT of abdomen which was mostly normal except for mildly enlarged gallbladder and a duodenal diverticulum. She was referred to GI and seen on 7/7 at which time she was prescribed zofran, advised to start Pepcid and and EGD and ECHO were ordered. In ER she was noted to be hypertensive, however labs were relatively unremarkable.  EKG showed bradycardia and nonspecific ST-T changes, troponins flat.  Chest x-ray was negative.  Patient had a reaction to IV Reglan in ER including dyskinesia and anxiety which resolved with Benadryl. CT abdomen/pelvis with IVC was negative.  She tested positive for COVID. Her only symptom included a runny nose that started on 07/15.    Patient was given supportive treatment with IV fluids, antiemetics and empiric PPI.  GI was consulted given her acute on chronic n/v and felt etiology remained unclear. They favored not pursuing EGD given her COVID symptoms and recommended keeping scheduled outpatient EGD on 8/9.  Diet was restarted.  Given her exertional nature of N/V, ECHO was done which showed LVEF 55% with mild mitral regurg. No major valvular disease and no WMA noted. Her nausea resolved while inpatient even with ambulation around her room. Discussed that this may be in part due to calcium being held while inpatient. Recommended monitoring symptoms and trying to correlate with whether calcium supp may be contributing. Also advised continuing zofran at home as this seems to be helping, and considering trying protonix rather than pepcid since symptoms improved while taking this. Also suggested following GERD diet and monitoring for improvement. Patient and daughter agreeable to trying these steps and following up for EGD on 8/9. If symptoms persistent and no findings on endoscopy, could consider further cardiac workup, possibly stress test.    She was noted to have pulmonary nodules in the right lung and hence noncontrast CT was done which showed mild bilateral atelectasis. Mild bilateral costophrenic granulomas were note and moderate calcified atherosclerosis of LAD.  She is a lifelong nonsmoker.   She was noted to have incidental COVID-19 infection, with symptoms of runny nose and dry cough that started on 07/15.  Provided no therapeutics as her only symptoms was nasal congestion
had them and shot/suspected vaccination failure; had them; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Concurrent medical conditions included allergy to vaccine (was allergic to shot).   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: had them and shot/suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: had them). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK receipt date: 22-Apr-2023 The case was received from the patient via interactive digital media. The patient had them, was not bad for him or her because he or she went to the physician quick. This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
pt recv vax & exp aching in the joints & bones;ER or MD visit was required to treat the events which persist;
High dose IM 3V. Symptoms are stomach pain and nausea, tiredness. Going on almost 5 days on and off. Some coughing and congestion.
9/23/14 Fever 100.6 degrees F, chills, right arm soreness, no redness, no SOB, no swelling, no warmth. 9/24/14 Chills, fever, injection site painful and warm to touch, fatigue, redness. Treatment on 9/24 labs, Amoxicillin.
Pt recvd 2 doses of vax & p/2nd dose pt exp polymyalgia, pain, fatigue & became stiff w/aches; pt also had inc sed rate;
Approx 7 minutes after receiving the vaccine, client started c/o tingling in her left hand and the tip of her tongue. Vitals monitored, oxygen applied per nasal cannula. Her symptoms resolved very quickly without the use of medications. She also c/o metallic taste in her mouth. She was upset bc she had to wait 2 hours to get the shot and then had to be  monitored for 1hr and 45 minutes after the vaccine.  She did have one previous reaction to a pain shot in the past.
Site: Redness at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Severe, Systemic: Seizure-Severe, Systemic: Shakiness-Mild
Sick; headache; muscle pain; joint pain; feeling very fatigued; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain), FATIGUE (feeling very fatigued) and ILLNESS (Sick) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In June 1900, the patient experienced FATIGUE (feeling very fatigued). In June 2021, the patient experienced HEADACHE (headache), MYALGIA (muscle pain) and ARTHRALGIA (joint pain). On an unknown date, the patient experienced ILLNESS (Sick). At the time of the report, HEADACHE (headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain), FATIGUE (feeling very fatigued) and ILLNESS (Sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication use was unknown Treatment information was unknown
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 12/24/20 pfizer,Lot#EK9231 2nd dose: 01/13/21Pfizer,Lot# EL3248 Diagnosed covid positive:08/09/21 Symptom onset:08/06/21 Exposure:work Symptoms:fever, fatigue,chills headache muscle aches.
It was reported that a 47 year old female patient received a Fluzone SV vaccination on 11/15/2000. Reportedly on 11/16/2000, the patient complained of redness, swelling, itching and warmth at the site of injection. The vaccine was administered in the upper arm, below the deltoid.
Information has been received from a registered nurse concerning a patient who was vaccinated with a second 2ml dose of ROTATEQ (lot number not reported) orally earlier than 6 weeks.  There was no information on first dose.  No adverse effect was involved.  It was unknown if the patient had sought medical attention.  Additional information has been requested.
Pt came to vaccine clinic run by a local facility on 5/20/2021, filled out encounter as this being the 1st dose of COVID vaccine, on encounter the answer no is checked where asking, "Have you ever received a dose of COVID 19 vaccine?"  When the encounter was entered into the portal, it was discovered the pt had received a dose of Pfizer vaccine on 4/2/2021. After multiple attempts to contact pt, this nurse spoke with her on the  phone 5/25/21, pt confirmed receiving Pfizer vaccine on 4/2/21. She was advised by a pharmacist and Dr. to restart the vaccine series using Moderna.  This nurse advised pt she did not need to restart the vaccine, that she had received two doses and this should complete the series for her. Pt plans to consult with her doctor as to whether to get a second dose of Moderna. This nurse advised it is unnecessary to receive another moderna vaccine and it is not recommended to mix the vaccine brands.  Pt verbalized understanding.
Numbness in feet/legs; and muscle spasms in legs started February 15, 2022. Visited doctor. CAT scan and follow-up with neurologist scheduled.
SWELLING  OF THE ARM, FEVER ,TIRED, HEADACHE, NECK STIFFNESS AND CHEST TIGHTNESS.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On an unknown date in 2012, the patient was inoculated with ZOSTAVAX by a physician as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. On an unknown date in 2014, the patient was treated the same physician for a blistering vesicular outbreak which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
big knot painful, Pt believes vaccine was injected on wrong area,  on the upper left arm but distal side of arm (lower than the deltoid)
inflamed my zoster virus meniere's disease dizziness loss of hearing loss of balance fatigue lethargy brain fog covid 19 but with neg test results
6 hrs after H1N1, Tdap had increasing L arm (Tdap) pain, nausea, headache and blurred vision. Blurred vision lasted 10 min but nausea and headache persist. Exam today, (1 day after immunizations) was negative.
Vaccine at 12:50  20 minutes after shot: fuzzy, drugged  35 minutes after: face and neck was red and blotchy and itchy. Tongue was itchy. Pain at injection site  Drive home was bad. Slurring my words. Eyes were so heavy, hard to keep open. I felt weight on me. Pressure on my chest, heart was tight. Fatigue.   Started hysterically crying.  Got home, couldn?t walk normally. Sweating.   Chills started at 8  Body aches at 9  Woke up with TERRIBLE body aches at 11:40. Skin was so hot, I was shivering cold. My legs hurt so bad. My knees mostly. My ankles. My inner thigh muscles. My lower back couldn?t handle any pressure. It hurt to lay. My left shoulder blade and upper arm hurt bad. Then my head hurt. My hips couldn?t move. My elbow felt weak and painful, like they would break.   12:40 headache got worse. I was shaking. I was nauseous. Chills were awful. Ears were ringing.   No appetite for days.   Sore joints, muscle pain and fatigue still 4/13
Day after vaccine - chills, fever, headache , body aches, nausea  2 days later painful red area 3 to 4 inches below injection site progressed to large raised red, painful  itchy area by day 3 still ongoing at time of report
Swelling of skin this morniing 2/14/14 no fever; itching and pain on pressure (L) arm at site of varicella and milder reaction at site of KINRIX.
Fever (102.6 x 48hrs), Mialgia, Nausua, Diahrrea, severe weakness, dizziness, confusion. Abominal pain & cramps. Left upper arm pain. Symptom course lasted total 5 days and completely resolved by Sunday evening(4/18/21)
Oone week after being vaccinated, the patient began to crawl awkwardly and cry when crawling, within a day the patient was unable to stand and was crying more often than usual. The evening he was taken to the ER, he was unable to stand or crawl and appeared to be in severe pain. it was determined that the patient had Toxic Synovitis in his hip.
Mom describes 2 seizures at 0630 and 0730. Jerking motions of head and arms, lethargic after. Mom spoke to emergency room and brought child to our office, arriving about 0830. Child immediately escorted to emergency room upon arrival to office.  Nurse follow up on 07/12/04 states: "Rickets, hypocalcemia, vitamin D deficiency, metabolic acidosis, febrile illness."
About a week after the first shot I started to have Achilles pain which I had never had before.  Several weeks later, I started having problems controlling my bladder.  I had increased frequency and urgency. I had to start wearing diapers because I kept losing control.   Muscle soreness also increased all over my body.  My body was very stiff.  I was a collegiate athlete and suddenly I felt like a prisoner trapped in my own body, unable to move.  After each shot, my symptoms worsened.  I became increasingly tired all of the time and only wanted to sleep during the day.  My eyes were also extremely dry and I would get cuts all over my hands-signs of arthritis.
HYPOXIC; LIGHTHEADED; FELT LIKE BRAIN DID A BACKFLIP/FEEL LIKE HE WAS ON A BOAT IN HEAVY SEAS AND HEAD IS FLOATING; ARMS AND LEGS FEELS CONCRETE; NAUSEOUS; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total administered on 16-MAR-2021 for prophylactic vaccination. The batch number was not reported. We are unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. After the administration of vaccine patient felt fine and left after the 15 minutes. On 16-MAR-2021, the patient experienced hypoxic, lightheaded, felt like brain did a backflip/feel like he was on a boat in heavy seas and head is floating, arms and legs feels concrete and nauseous. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the nauseous, lightheaded, hypoxic, felt like brain did a backflip/feel like he was on a boat in heavy seas and head is floating and arms and legs feels concrete was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210331371-covid-19 vaccine ad26.cov2.s-Hypoxia. This event is considered Unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
This spontaneous report was received from a pharmacist concerning a female patient of unknown age. The patient's concurrent conditions, medical history and concomitant medications were not reported. On an unknown date, at pharmacy, the patient was vaccinated with ZOSTAVAX, intramuscularly (incorrect route of drug administration) (dose, lot number expiration date were not reported) instead of VARIVAX, for prophylaxis. On an unknown date, the patient experienced cellulitis on an unknown area of deltoid. The outcome of cellulitis was not reported. The relatedness between the event and ZOSTAVAX was not reported. Upon internal review cellulitis on an unknown area of deltoid was considered to be medically significant. Additional information has been requested.
Patient received vaccine affected by the excursion; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received vaccine affected by the excursion) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jun-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received vaccine affected by the excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received vaccine affected by the excursion) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received vaccine affected by the excursion) to be not related.    The expiration date of  lot # in question LOT: 009D21A was 02-Jul-2021 and the excursion event occurred on 09-Jun-2021.  No concomitant medications information was provided. No treatment medications information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Follow Up received on 27 Jul 2021 contains Updated Causality of Events, lot expiration date. Expired product administered was removed..
more than 36 days after the first dose without receiving second dose; This spontaneous case was reported by a consumer and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (more than 36 days after the first dose without receiving second dose) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included Breast cancer (history of breast cancer that affected left arm). Concurrent medical conditions included Back pain.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (more than 36 days after the first dose without receiving second dose). At the time of the report, INTENTIONAL PRODUCT USE ISSUE (more than 36 days after the first dose without receiving second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant Medication was available. No Treatment Medication was available. Patient stated that the 2nd dose was scheduled on 12Mar2021 but had a back pain management surgery that was scheduled on the same day where she was receiving injection shots
Coughing up dark blood on the 16th of September . went to ER and Discovered blood clots in lungs.
Information has been received from a nurse practitioner concerning a 4 year old patient who was vaccinated with a single dose of Proquad. Subsequently the patient developed a rash which did not appear to be wild-type chicken pox. No additional information regarding the nature of the rash was provided. The prior vaccine history of the patient was not provided. Unspecified medical attention was sought. No product quality complaint was involved. The patient's six month old sibling also broke out with the same type of rash which did not appear to be wild-type chicken pox following this vaccination with Proquad. (WAES0706USA02678). Additional information has been requested.
presented after being found down by neighbors. initial concern for R MCA stroke, though CT brain without clear evidence of stroke. has been admitted with persistent encephalopathy of unknown cause.
Information has been received from a registered nurse referring to an unspecified number of patients of unknown age and gender. Information about medical history and concurrent condition was not reported. On unknown dates since 13-JUL-2015, the patients were administered with ROTATEQ (lot # K016313 with expiration date of 31 MAY 2016)(strength, dose, route and lot  number unspecified). which were exposed to temperatures outside of the recommended range (incorrect product storage). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
I am not sure if this is worth reporting, but a med professional (trusted acquaintance) said I should. 2nd shot at 10:45am  3/4/21 All was fine till 5:55am  3/5/21  - Then vomiting liquid, much diarrhea   . .  a 2nd set of vomiting . . . headache  . . . then Diarrhea at fairly frequent intervals (at last every hour) till maybe 6pm evening.  Then less frequently (bigger intervals - maybe 4 times) till about 5am 3/6/21.  Then it more or less stopped.  Headache left, and though the stomach was worked over, I was now feeling better. Other than a rough night. All this time I had been rehydrating  frequently - trying to keep pace with discharge . . . (fizzy water - no additives) sometimes cut with a very little cranberry juice.  Since then  BRAT and now back to almost normal.   4lb lighter . . . That's good.
This spontaneous report was received from a nurse prescriber and refers to unspecified patients of unknown ages and genders. There was no information about patients' concomitant medications and pertinent medical history reported. On an unknown date, the patients were vaccinated with doses of improperly stored VARIVAX, lot number  M035140 and expiration date 03-AUG-2018 (route of administration and anatomical location were not reported) for prophylaxis. The vaccines were stored at a lowest recorded temperature of  5F (-15 Celsius) and highest 14F (-10 Celsius) for 30 minutes due to a data logger issue. No previous temperature excursion was reported.  No adverse effects were reported. No product quality complaint was involved. Additional information has been requested.
hair lose; This is a spontaneous report from a contactable consumer (patient). A 58-years-old female patient received first dose of bnt162b2 (COMIRNATY) via unspecified route of administration in the arm left, on 07Jun2021, at the age of 58-years-old, at single dose for COVID-19 immunization. Patient medical history included COVID-19 on unspecified date, prior vaccination. Concomitant medications were not reported.  The patient experienced hair loss (hair lose) on unspecified date in 2021. Event caused hospitalization on unspecified date in 2021 for 12 days.  Outcome of the event was recovered with lasting effects (recovered with sequel) on unspecified date in 2021.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Headache, fatigue, nausea, diarrhea, 102 fever, and body aches started 11 hours after the vaccine. Joint pain began the next day. Most of these symptoms improved after 4 days in bed, but the headache and fatigue have continued almost daily since the 2nd vaccine. This has also included migraines with light sensitivity and nausea. She has not had migraines previously. She has also had irregular menstrual cycles. She has had three menstrual periods within the past 6 weeks. Her normal cycle is 42 days. On 9/22/21, she had eye inflammation which she saw her eye doctor for. They believe it was just an ingrown eyelash. She felt lightheaded at this visit and passed out. She had also passed out after her first vaccine. She had an episode of feeling nauseated once at a doctor visit when she was younger, but had never passed out. On 9/24/21 she began having a sore throat, congestion, body aches, low grade fever, nausea, diarrhea, and continued headache and fatigue. She visited with a doctor on 9/25/21 who advised it was probably a viral infection, but that she should be tested for Covid. Later that night, she lost her sense of taste and smell. She was tested for Covid on 9/27/21. Her results were negative. Her symptoms have improved, but she continues to have headache, fatigue, congestion, and a sore throat.